Get breaking ophthalmic news, device and drug updates, clinical trial coverage, thought-leader perspective, and industry announcements.

Get breaking ophthalmic news, device and drug updates, clinical trial coverage, thought-leader perspective, and industry announcements.

Key Takeaways Neera Clase, who has served as interim CCO of Tarsus Pharmaceuticals since July, was appointed as the company’s ...

The discovery could advance understanding of glaucoma, age-related macular degeneration, and other ocular diseases, although studies in humans are needed Researchers from the University of British ...

The first patient has been dosed in Nacuity Pharmaceuticals’ global, confirmatory phase 3 clinical trial of NPI-001 tablets for the treatment of retinitis pigmentosa associated with Usher Syndrome.

A study recently published in BMJ Open evaluated the first implementation cycle of a comprehensive 3-year cataract outreach program in Sierra Leone The study found that the program has improved ...

The reorganization is designed to reduce operating expenses and prioritize consumer marketing for its presbyopia treatment Vizz generated $2.6 million in third-quarter sales, with paid prescriptions ...

Glaukos and RevOpsis Therapeutics have entered into an exclusive license agreement to develop and commercialize RO-104, a tri-specific biologic for the treatment for retinal disease The agreement ...

VisioSurgical Solutions announced its launch and the start of development of a compact surgical robot for retinal surgery with Kaleidoscope Innovation The founding team of VisioSurgical Solutions ...

Ms/ Mehta brings extensive NHS governance experience and more than 20 years in international financial services Moorfields Eye Hospital has appointed Aruna Mehta as its new chair, effective November 1 ...

Kiora has obtained exclusive rights outside Asia to KIO-401, an investigational oral calpain inhibitor being developed for CRAO and NAION Clinical studies conducted in Japan reported improvements in ...